A detailed history of Massmutual Trust CO Fsb transactions in Novavax Inc stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 72 shares of NVAX stock, worth $609. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72
Holding current value
$609
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

BUY
$10.71 - $17.11 $771 - $1,231
72 New
72 $0
Q3 2022

Oct 07, 2022

BUY
$18.2 - $76.12 $964 - $4,034
53 New
53 $1,000
Q1 2022

Apr 08, 2022

SELL
$69.73 - $142.9 $278 - $571
-4 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$134.56 - $217.97 $538 - $871
4 New
4 $1,000
Q1 2021

May 17, 2021

SELL
$112.98 - $319.93 $11,298 - $31,993
-100 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$78.74 - $139.5 $7,873 - $13,950
100 New
100 $11,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.